4-(3-((1-(3-((4-(1H-imidazol-1-yl)-2-methylquinolin-8-yloxy)methyl)-2,4-dichlorophenyl)-1H-pyrrol-2-yl)methylamino)-3-oxoprop-1-enyl)-N,N-dimethylbenzamide

ID: ALA1189175

Chembl Id: CHEMBL1189175

Max Phase: Preclinical

Molecular Formula: C37H32Cl2N6O3

Molecular Weight: 679.61

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(-n2ccnc2)c2cccc(OCc3c(Cl)ccc(-n4cccc4CNC(=O)/C=C/c4ccc(C(=O)N(C)C)cc4)c3Cl)c2n1

Standard InChI:  InChI=1S/C37H32Cl2N6O3/c1-24-20-32(44-19-17-40-23-44)28-7-4-8-33(36(28)42-24)48-22-29-30(38)14-15-31(35(29)39)45-18-5-6-27(45)21-41-34(46)16-11-25-9-12-26(13-10-25)37(47)43(2)3/h4-20,23H,21-22H2,1-3H3,(H,41,46)/b16-11+

Standard InChI Key:  MESWIKFMVZMDSV-LFIBNONCSA-N

Associated Targets(Human)

BDKRB2 Tclin Bradykinin B2 receptor (3970 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 679.61Molecular Weight (Monoisotopic): 678.1913AlogP: 7.44#Rotatable Bonds: 10
Polar Surface Area: 94.28Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 6.18CX LogP: 6.28CX LogD: 6.26
Aromatic Rings: 6Heavy Atoms: 48QED Weighted: 0.15Np Likeness Score: -1.42

References

1. Gaikwad N, Nanduri S, Madhavi YV..  (2019)  Cinnamamide: An insight into the pharmacological advances and structure-activity relationships.,  181  [PMID:31376564] [10.1016/j.ejmech.2019.07.064]

Source